2021 AGO建议：早期乳腺癌患者的诊断与治疗（更新版）

2021-06-16 德国妇科肿瘤小组 Breast Care (Basel). 2021 Jun;16(3):214-227.

2021年6月，德国妇科肿瘤小组(AGO)发布了早期乳腺癌患者的诊断与治疗建议。德国妇科肿瘤小组(AGO)一直在准备以及更新关于早期和转移性乳腺癌的诊断和治疗建议，2021更新版早期乳腺癌诊断和治疗建

中文标题：

英文标题：

AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2021

发布机构：

德国妇科肿瘤小组

发布日期：

2021-06-16

简要介绍：

2021年6月，德国妇科肿瘤小组(AGO)发布了早期乳腺癌患者的诊断与治疗建议。德国妇科肿瘤小组(AGO)一直在准备以及更新关于早期和转移性乳腺癌的诊断和治疗建议，2021更新版早期乳腺癌诊断和治疗建议的主要内容涉及乳腺癌一级预防，风险评估和预防，乳腺癌的诊断，病理临床治疗等。

相关资料下载：

GetToolGuiderByIdResponse(projectId=1, id=406031c00213e979, title=2021 AGO建议：早期乳腺癌患者的诊断与治疗（更新版）, enTitle=AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2021, guiderFrom=Breast Care (Basel). 2021 Jun;16(3):214-227., authorId=0, author=, summary=2021年6月，德国妇科肿瘤小组(AGO)发布了早期乳腺癌患者的诊断与治疗建议。德国妇科肿瘤小组(AGO)一直在准备以及更新关于早期和转移性乳腺癌的诊断和治疗建议，2021更新版早期乳腺癌诊断和治疗建, cover=https://img.medsci.cn/2021728/1627484615726_2020535.jpg, journalId=0, articlesId=null, associationId=1692, associationName=德国妇科肿瘤小组, associationIntro=, copyright=0, guiderPublishedTime=Wed Jun 16 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2021年6月，德国妇科肿瘤小组(AGO)发布了早期乳腺癌患者的诊断与治疗建议。德国妇科肿瘤小组(AGO)一直在准备以及更新关于早期和转移性乳腺癌的诊断和治疗建议，2021更新版早期乳腺癌诊断和治疗建议的主要内容涉及乳腺癌一级预防，风险评估和预防，乳腺癌的诊断，病理临床治疗等。</p> </div> </div> </div> <div class="box_info" style="color: #373737;"> </div>, tagList=[TagDto(tagId=285, tagName=乳腺癌)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=89, categoryName=乳腺癌, tenant=100), CategoryDto(categoryId=20620, categoryName=肿瘤医学网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=285, guiderKeyword=乳腺癌, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=8428, appHits=179, showAppHits=0, pcHits=651, showPcHits=8245, likes=0, shares=7, comments=17, approvalStatus=1, publishedTime=Wed Jul 28 23:25:58 CST 2021, publishedTimeString=2021-06-16, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Wed Jul 28 23:03:45 CST 2021, updatedBy=4754896, updatedName=fbzhang, updatedTime=Fri Jan 05 19:35:36 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 AGO建议：早期乳腺癌患者的诊断与治疗（更新版）.pdf)])

2021 AGO建议：早期乳腺癌患者的诊断与治疗（更新版）.pdf

下载请点击：

评论区 (13)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=1229674, encodeId=e6c912296e41a, content=最好有中文版, beContent=null, objectType=guider, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=551f6577885, createdName=ms2000000607989566, createdTime=Thu Jun 30 10:35:20 CST 2022, time=2022-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200564, encodeId=4e5512005648b, content=中文版？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b415562646, createdName=ms9000001873897494, createdTime=Tue Mar 08 15:28:23 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200562, encodeId=2f5b120056208, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b415562646, createdName=ms9000001873897494, createdTime=Tue Mar 08 15:27:46 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184985, encodeId=9d6711849855b, content=非常棒👍🏻👍🏻👍🏻👍🏻, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=de232193495, createdName=1209b8a9m19暂无昵称, createdTime=Sun Jan 16 22:43:02 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184984, encodeId=59a011849849f, content=很好呀, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=de232193495, createdName=1209b8a9m19暂无昵称, createdTime=Sun Jan 16 22:42:51 CST 2022, time=2022-01-16, status=1, ipAttribution=)]
2022-06-30 ms2000000607989566

最好有中文版

33 0
[GetPortalCommentsPageByObjectIdResponse(id=1229674, encodeId=e6c912296e41a, content=最好有中文版, beContent=null, objectType=guider, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=551f6577885, createdName=ms2000000607989566, createdTime=Thu Jun 30 10:35:20 CST 2022, time=2022-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200564, encodeId=4e5512005648b, content=中文版？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b415562646, createdName=ms9000001873897494, createdTime=Tue Mar 08 15:28:23 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200562, encodeId=2f5b120056208, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b415562646, createdName=ms9000001873897494, createdTime=Tue Mar 08 15:27:46 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184985, encodeId=9d6711849855b, content=非常棒👍🏻👍🏻👍🏻👍🏻, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=de232193495, createdName=1209b8a9m19暂无昵称, createdTime=Sun Jan 16 22:43:02 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184984, encodeId=59a011849849f, content=很好呀, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=de232193495, createdName=1209b8a9m19暂无昵称, createdTime=Sun Jan 16 22:42:51 CST 2022, time=2022-01-16, status=1, ipAttribution=)]
2022-03-08 ms9000001873897494

中文版？

35 0
[GetPortalCommentsPageByObjectIdResponse(id=1229674, encodeId=e6c912296e41a, content=最好有中文版, beContent=null, objectType=guider, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=551f6577885, createdName=ms2000000607989566, createdTime=Thu Jun 30 10:35:20 CST 2022, time=2022-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200564, encodeId=4e5512005648b, content=中文版？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b415562646, createdName=ms9000001873897494, createdTime=Tue Mar 08 15:28:23 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200562, encodeId=2f5b120056208, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b415562646, createdName=ms9000001873897494, createdTime=Tue Mar 08 15:27:46 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184985, encodeId=9d6711849855b, content=非常棒👍🏻👍🏻👍🏻👍🏻, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=de232193495, createdName=1209b8a9m19暂无昵称, createdTime=Sun Jan 16 22:43:02 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184984, encodeId=59a011849849f, content=很好呀, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=de232193495, createdName=1209b8a9m19暂无昵称, createdTime=Sun Jan 16 22:42:51 CST 2022, time=2022-01-16, status=1, ipAttribution=)]
2022-03-08 ms9000001873897494

很好

48 0
[GetPortalCommentsPageByObjectIdResponse(id=1229674, encodeId=e6c912296e41a, content=最好有中文版, beContent=null, objectType=guider, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=551f6577885, createdName=ms2000000607989566, createdTime=Thu Jun 30 10:35:20 CST 2022, time=2022-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200564, encodeId=4e5512005648b, content=中文版？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b415562646, createdName=ms9000001873897494, createdTime=Tue Mar 08 15:28:23 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200562, encodeId=2f5b120056208, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b415562646, createdName=ms9000001873897494, createdTime=Tue Mar 08 15:27:46 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184985, encodeId=9d6711849855b, content=非常棒👍🏻👍🏻👍🏻👍🏻, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=de232193495, createdName=1209b8a9m19暂无昵称, createdTime=Sun Jan 16 22:43:02 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184984, encodeId=59a011849849f, content=很好呀, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=de232193495, createdName=1209b8a9m19暂无昵称, createdTime=Sun Jan 16 22:42:51 CST 2022, time=2022-01-16, status=1, ipAttribution=)]
2022-01-16 1209b8a9m19暂无昵称

非常棒👍🏻👍🏻👍🏻👍🏻

39 0
[GetPortalCommentsPageByObjectIdResponse(id=1229674, encodeId=e6c912296e41a, content=最好有中文版, beContent=null, objectType=guider, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=551f6577885, createdName=ms2000000607989566, createdTime=Thu Jun 30 10:35:20 CST 2022, time=2022-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200564, encodeId=4e5512005648b, content=中文版？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b415562646, createdName=ms9000001873897494, createdTime=Tue Mar 08 15:28:23 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200562, encodeId=2f5b120056208, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b415562646, createdName=ms9000001873897494, createdTime=Tue Mar 08 15:27:46 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184985, encodeId=9d6711849855b, content=非常棒👍🏻👍🏻👍🏻👍🏻, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=de232193495, createdName=1209b8a9m19暂无昵称, createdTime=Sun Jan 16 22:43:02 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184984, encodeId=59a011849849f, content=很好呀, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=de232193495, createdName=1209b8a9m19暂无昵称, createdTime=Sun Jan 16 22:42:51 CST 2022, time=2022-01-16, status=1, ipAttribution=)]
2022-01-16 1209b8a9m19暂无昵称

很好呀

37 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

肿瘤科指南

2021 AGO建议：早期乳腺癌患者的诊断与治疗（更新版）

相关指南

拓展阅读

科室

工具

服务